| |
| |
|
| Insider
Information: |
Easom Eric |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
101,130 |
|
|
Indirect Shares
|
1,209,882 |
|
|
| Direct
Value |
$244,735 |
|
|
|
Indirect Value
|
$2,927,914 |
|
|
| Total
Shares |
1,311,012 |
|
|
| Total
Value |
$3,172,649 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
An2 Therapeutics Ord Shs |
ANTX |
|
2024-03-15 |
101,130 |
2024-03-15 |
1,209,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
99,000 |
101,130 |
0 |
- |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2024-01-02 |
4 |
AS |
$20.09 |
$55,802 |
D/D |
(2,777) |
2,130 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2023-05-15 |
4 |
B |
$5.38 |
$53,770 |
I/I |
10,000 |
1,015,766 |
2.66 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-11-14 |
4 |
AS |
$15.04 |
$346 |
D/D |
(23) |
4,907 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-11-10 |
4 |
AS |
$15.32 |
$67,628 |
D/D |
(4,413) |
4,930 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-11-09 |
4 |
AS |
$15.61 |
$157,847 |
D/D |
(10,111) |
4,907 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-11-08 |
4 |
AS |
$15.41 |
$109,947 |
D/D |
(7,055) |
15,018 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-11-07 |
4 |
AS |
$15.90 |
$195,741 |
D/D |
(12,203) |
4,907 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-11-04 |
4 |
AS |
$15.80 |
$139,474 |
D/D |
(8,828) |
17,110 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-11-03 |
4 |
AS |
$15.67 |
$223,058 |
D/D |
(14,165) |
25,938 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-11-02 |
4 |
AS |
$15.07 |
$23,263 |
D/D |
(1,544) |
4,907 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-10-31 |
4 |
AS |
$15.39 |
$41,363 |
D/D |
(2,688) |
6,451 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-10-26 |
4 |
AS |
$15.10 |
$25,342 |
D/D |
(1,678) |
4,907 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-10-25 |
4 |
AS |
$15.69 |
$75,672 |
D/D |
(4,806) |
6,585 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-10-24 |
4 |
AS |
$16.17 |
$46,344 |
D/D |
(2,866) |
11,391 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-10-21 |
4 |
AS |
$16.29 |
$228,240 |
D/D |
(13,951) |
4,907 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-10-20 |
4 |
AS |
$16.68 |
$121,672 |
D/D |
(7,293) |
18,858 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive Officer |
• • – |
2022-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,907 |
4,907 |
0 |
- |
|
| ANTX |
An2 Therapeutics Ord Shs |
Chief Executive OfficerOfficer |
• • – |
2022-03-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,294,113 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
